Stem Cell Therapies Market
Stem Cell Therapies Market by Type, Therapeutic Application, Cell Source & Region - Forecast 2022 - 2032
Market Insights on Stem Cell Therapies covering sales outlook, demand forecast and up-to-date key trends
Stem Cell Therapies Market Overview (2022-2032)
[250 Pages Report] The stem cell therapy market is expected to grow at a CAGR of 16.7% to USD 401 million by 2026, up from USD 187 million in 2021.
Attributes |
Details |
Stem Cell Therapy Market (CAGR) |
16.7% |
Stem Cell Therapy Market (2026) |
USD 401 million |
Stem Cell Therapy Market (2021) |
USD 187 million |
Factors such as expanding stem cell research activities and increasing approvals of GMP-certified facilities to generate stem cells are driving stem cell therapy market expansion.
In the next years, the growing need for iPSCs as an alternative to ESCs, as well as the expanding demand for cell and gene treatments, are projected to promote the expansion of the stem cell therapy market.
What has been the Impact of COVID-19 on Stem Cell Therapy Market?
On March 11, 2020, the World Health Organization (WHO) proclaimed COVID-19 a pandemic. To combat the epidemic, researchers have been developing novel cures and treatments. Stem cells have been shown to be a successful treatment for pulmonary illnesses, especially COVID-19, in recent years.
At least 10 projects have been registered in the official international registry for clinical trials, implicating the use of mesenchymal stem cells to patients with coronavirus pneumonia hence increasing the demand for stem cell therapy and sales of stem cell therapy.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
What are the Drivers Contributing to the Growth of the Stem Cell Therapy Market?
The demand for innovative and better medicines to treat autoimmune, neurological, and cardiovascular disorders has led to a surge in demand for stem cell therapy and sales of stem cell therapy and research activity and funding for cell-based research.
Ethical considerations about embryonic stem cells are a source of restraint for the stem cell therapy market.
As stem cells are obtained by killing a human embryo, several ethical concerns are involved with the demand for stem cell therapy. A human embryo is seen as potential life, and eliminating them is considered immoral even if it can save a human life. Concerns about using embryonic stem cells to produce stem cell therapies limit stem cell therapy market expansion and the sales of stem cell therapy.
What are the Future Opportunities of the Stem Cell Therapy Market?
Adult stem cells that have been genetically reprogrammed to resemble embryonic stem cells are known as induced pluripotent stem cells (iPSCs). iPSCs are becoming a viable alternative to ESCs for the stem cell therapy market.
ESCs are involved with socio-ethical concerns and legislation about contraception, abortion, and in vitro fertilization since they are derived from early-stage embryos. The use of iPSCs avoids using human embryos, eliminating social and ethical concerns surging the demand for stem cell therapy with increased sales of stem cell therapy.
What is the Regional Outlook of Stem Cell Therapy Market?
North America, Asia Pacific, and Europe accounted for the highest proportion of the stem cell therapy market.
This geographical segment's substantial proportion of the stem cell therapy market is largely due to the increased public-private financing and research grants for producing safe and effective stem cell treatment products, as well as the expanding number of clinical trials, can be ascribed to North America's major part of the stem cell therapy market with increased sales of stem cell therapy.
How is the Stem Cell Therapy Market Segmented based on Type?
Allogeneic stem cell treatment had the prominent demand for stem cell therapy and sales of stem cell therapy.
The stem cell therapy market is divided into two types, i.e., allogeneic stem cell therapy and autologous stem cell therapy. The allogeneic category held the most significant proportion for demand for stem cell therapy in the stem cell therapy market.
The simplicity of manufacturing and production methods, as well as the increased availability of innovative stem cell products across critical countries, are contributing to the allogeneic segment's rise in the stem cell therapy market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
How is the Stem Cell Therapy Market Segmented on the basis of Therapeutic Application?
During the predicted period, the sector of inflammatory and autoimmune illnesses will have the highest sales of stem cell therapy.
The stem cell therapy market is divided into musculoskeletal disorders, wounds and injuries, cardiovascular illnesses, surgeries, inflammatory and autoimmune diseases, neurological disorders, and other therapeutic applications based on therapeutic.
Due to the rising frequency of neurological illnesses and the high cost of therapy, the sales of stem cell therapy and demand for stem cell therapy neurological disorders category are predicted to increase at the fastest CAGR over the forecast period.
How is the Stem Cell Therapy Market Segmented on the basis of End Use?
Hospitals and research institutes are partnering to improve treatment options, therefore, escalat6ing demand for stem cell therapy along with sales of stem cell therapy.
The end-use category of hospitals is expected to grow by roughly 10.6% through 2027.
The stem cell therapy market is growing because of a growing demand for stem cell therapy and sales of stem cell therapy in hospitals to minimize difficulties caused by intrusive approaches such as surgical procedures.
Hospitals are associated with research facilities and academic institutes that do considerable research to develop novel stem cell therapy. Collaborations with research institutions enable hospitals to improve their treatment options and, as a result, have a favorable impact on stem cell therapy market statistics.
Who are the Key Market Players of the Stem Cell Therapy Market?
Key players in the stem cell therapy market include Smith & Nephew (UK, MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), PHARMICELL Co., Ltd. (South Korea), JCR Pharmaceuticals Co., Ltd. (Japan), and NuVasive, Inc. (US).
In March 2021, Novadip Biosciences received approval from U.S. FDA for the Company's Investigational New Drug (IND) application for its autologous cell therapy product NVD-003. The product is used to treat Congenital Pseudarthrosis of the Tibia (CPT).
This strategy is likely to enhance its product offerings and expand its customer base as well as sales of stem cell therapy and demand for stem cell therapy, thereby strengthening its position in the stem cell therapy market.
In August 2020, Cipla and Stempeutics collaborated to launch Stempucel cell therapy to treat critical limb ischemia to grab the largest stem cell therapy market share.
Scope Of Report
Report Attribute |
Details |
Growth rate |
CAGR of 16.7% from 2022 to 2032 |
Base year for estimation |
2021 |
Historical data |
2015 – 2020 |
Forecast period |
2022 – 2032 |
Quantitative units |
Revenue in USD million, volume in kilotons, and CAGR from 2022 to 2032 |
Report coverage |
Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
Segments covered |
Type, application, cell source, region |
Regional scope |
North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand |
Country scope |
U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa |
Key companies profiled |
Smith & Nephew (UK), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), PHARMICELL Co., Ltd. (South Korea), JCR Pharmaceuticals Co., Ltd. (Japan), and NuVasive, Inc. (US) |
Customization scope |
Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. |
Key Segments
By Type:
- Allogeneic
- Autologous
By Therapeutic Application:
- Musculoskeletal
- Wound & Injury
- CVD
- Autoimmune & Inflammatory
By Cell Source:
- Adipose tissue
- Bone Marrow
- Placenta/Umbilical Cord
By Region:
- North America
- Latin America
- Asia Pacific
- MEA
- Europe
Frequently Asked Questions
What was the Valuation of Stem Cell Therapy Market in North America?
North America stem cell therapy market valued at USD 3.7 billion in 2020 and is forecast to expand at 10.3% CAGR.
What is the Demand for Stem Cell Therapy in the End Use Category?
The end-use category of hospitals is expected to grow by roughly 10.6% with escalated demand for stem cell therapy
Which Segment by Type has the Highest Stem Cell Therapy Market Share?
Oncology segment accounted for about 37.1% of the stem cell therapy market share.
Which Segment has the Fastest Growth in the Stem Cell Therapy Market Share?
Autologous segment in stem cell therapy market is projected to grow with a stem cell therapy market share of around 10.5%.
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Therapy Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Therapy Type, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Therapy Type, 2022-2032 5.3.1. Allogeneic Therapy 5.3.2. Autologous Therapy 5.4. Y-o-Y Growth Trend Analysis By Therapy Type, 2017-2021 5.5. Absolute $ Opportunity Analysis By Therapy Type, 2022-2032 Deep-dive segmentation will be available in the sample on request 6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Indication 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By Indication, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Indication, 2022-2032 6.3.1. Autoimmune Diseases 6.3.2. Musculoskeletal Disorders 6.3.3. Acute Graft Host Disease 6.3.4. Trauma Injuries 6.3.5. Others 6.4. Y-o-Y Growth Trend Analysis By Indication, 2017-2021 6.5. Absolute $ Opportunity Analysis By Indication, 2022-2032 Deep-dive segmentation will be available in the sample on request 7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032 7.3.1. Hospitals 7.3.2. Acute Care Facilities 7.3.3. Specialized Clinics 7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021 7.5. Absolute $ Opportunity Analysis By End User, 2022-2032 Deep-dive segmentation will be available in the sample on request 8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Stem Cell Type 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Mn) Analysis By Stem Cell Type, 2017-2021 8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Stem Cell Type, 2022-2032 8.3.1. Embryonic Stem Cells 8.3.2. Tissue-specific Stem Cells 8.3.3. Mesenchymal Stem Cells 8.3.4. Induced Pluripotent Stem Cells 8.4. Y-o-Y Growth Trend Analysis By Stem Cell Type, 2017-2021 8.5. Absolute $ Opportunity Analysis By Stem Cell Type, 2022-2032 Deep-dive segmentation will be available in the sample on request 9. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. East Asia 9.3.5. South Asia & Pacific 9.3.6. MEA 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. U.K. 10.2.1.2. Canada 10.2.2. By Therapy Type 10.2.3. By Indication 10.2.4. By End User 10.2.5. By Stem Cell Type 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Therapy Type 10.3.3. By Indication 10.3.4. By End User 10.3.5. By Stem Cell Type 10.4. Key Takeaways 11. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Therapy Type 11.2.3. By Indication 11.2.4. By End User 11.2.5. By Stem Cell Type 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Therapy Type 11.3.3. By Indication 11.3.4. By End User 11.3.5. By Stem Cell Type 11.4. Key Takeaways 12. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. U.K. 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Europe 12.2.2. By Therapy Type 12.2.3. By Indication 12.2.4. By End User 12.2.5. By Stem Cell Type 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Therapy Type 12.3.3. By Indication 12.3.4. By End User 12.3.5. By Stem Cell Type 12.4. Key Takeaways 13. East Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Therapy Type 13.2.3. By Indication 13.2.4. By End User 13.2.5. By Stem Cell Type 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Therapy Type 13.3.3. By Indication 13.3.4. By End User 13.3.5. By Stem Cell Type 13.4. Key Takeaways 14. South Asia & Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 14.2.1. By Country 14.2.1.1. India 14.2.1.2. Thailand 14.2.1.3. Indonesia 14.2.1.4. Malaysia 14.2.1.5. Singapore 14.2.1.6. Australia 14.2.1.7. New Zealand 14.2.1.8. Rest of South Asia & Pacific 14.2.2. By Therapy Type 14.2.3. By Indication 14.2.4. By End User 14.2.5. By Stem Cell Type 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Therapy Type 14.3.3. By Indication 14.3.4. By End User 14.3.5. By Stem Cell Type 14.4. Key Takeaways 15. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country 15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Therapy Type 15.2.3. By Indication 15.2.4. By End User 15.2.5. By Stem Cell Type 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Therapy Type 15.3.3. By Indication 15.3.4. By End User 15.3.5. By Stem Cell Type 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. U.K. 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2021 16.1.2.1. By Therapy Type 16.1.2.2. By Indication 16.1.2.3. By End User 16.1.2.4. By Stem Cell Type 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2021 16.2.2.1. By Therapy Type 16.2.2.2. By Indication 16.2.2.3. By End User 16.2.2.4. By Stem Cell Type 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2021 16.3.2.1. By Therapy Type 16.3.2.2. By Indication 16.3.2.3. By End User 16.3.2.4. By Stem Cell Type 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2021 16.4.2.1. By Therapy Type 16.4.2.2. By Indication 16.4.2.3. By End User 16.4.2.4. By Stem Cell Type 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2021 16.5.2.1. By Therapy Type 16.5.2.2. By Indication 16.5.2.3. By End User 16.5.2.4. By Stem Cell Type 16.6. U.K. 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2021 16.6.2.1. By Therapy Type 16.6.2.2. By Indication 16.6.2.3. By End User 16.6.2.4. By Stem Cell Type 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2021 16.7.2.1. By Therapy Type 16.7.2.2. By Indication 16.7.2.3. By End User 16.7.2.4. By Stem Cell Type 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2021 16.8.2.1. By Therapy Type 16.8.2.2. By Indication 16.8.2.3. By End User 16.8.2.4. By Stem Cell Type 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2021 16.9.2.1. By Therapy Type 16.9.2.2. By Indication 16.9.2.3. By End User 16.9.2.4. By Stem Cell Type 16.10. China 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2021 16.10.2.1. By Therapy Type 16.10.2.2. By Indication 16.10.2.3. By End User 16.10.2.4. By Stem Cell Type 16.11. Japan 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2021 16.11.2.1. By Therapy Type 16.11.2.2. By Indication 16.11.2.3. By End User 16.11.2.4. By Stem Cell Type 16.12. South Korea 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2021 16.12.2.1. By Therapy Type 16.12.2.2. By Indication 16.12.2.3. By End User 16.12.2.4. By Stem Cell Type 16.13. India 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2021 16.13.2.1. By Therapy Type 16.13.2.2. By Indication 16.13.2.3. By End User 16.13.2.4. By Stem Cell Type 16.14. Thailand 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2021 16.14.2.1. By Therapy Type 16.14.2.2. By Indication 16.14.2.3. By End User 16.14.2.4. By Stem Cell Type 16.15. Indonesia 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2021 16.15.2.1. By Therapy Type 16.15.2.2. By Indication 16.15.2.3. By End User 16.15.2.4. By Stem Cell Type 16.16. Malaysia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2021 16.16.2.1. By Therapy Type 16.16.2.2. By Indication 16.16.2.3. By End User 16.16.2.4. By Stem Cell Type 16.17. Singapore 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2021 16.17.2.1. By Therapy Type 16.17.2.2. By Indication 16.17.2.3. By End User 16.17.2.4. By Stem Cell Type 16.18. Australia 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2021 16.18.2.1. By Therapy Type 16.18.2.2. By Indication 16.18.2.3. By End User 16.18.2.4. By Stem Cell Type 16.19. New Zealand 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2021 16.19.2.1. By Therapy Type 16.19.2.2. By Indication 16.19.2.3. By End User 16.19.2.4. By Stem Cell Type 16.20. GCC Countries 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2021 16.20.2.1. By Therapy Type 16.20.2.2. By Indication 16.20.2.3. By End User 16.20.2.4. By Stem Cell Type 16.21. South Africa 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2021 16.21.2.1. By Therapy Type 16.21.2.2. By Indication 16.21.2.3. By End User 16.21.2.4. By Stem Cell Type 16.22. Israel 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2021 16.22.2.1. By Therapy Type 16.22.2.2. By Indication 16.22.2.3. By End User 16.22.2.4. By Stem Cell Type 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Therapy Type 17.3.3. By Indication 17.3.4. By End User 17.3.5. By Stem Cell Type 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Vericel Corporation 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Cyagen Biosciences, Inc. 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Stemcell Technologies Inc. 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Celegene Corporation 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Cellular Dynamics International 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Cytori Therapeutics, Inc. 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Fibrocell Science, Inc. 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Mesoblast Ltd 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Regeneus Ltd 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. EMD Millipore Corporation 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.11. ReNeuron Group plc 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.12. International Stem Cell Corporation 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Mn) Forecast by Region, 2017-2032 Table 2: Global Market Value (US$ Mn) Forecast by Therapy Type, 2017-2032 Table 3: Global Market Value (US$ Mn) Forecast by Indication, 2017-2032 Table 4: Global Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 5: Global Market Value (US$ Mn) Forecast by Stem Cell Type, 2017-2032 Table 6: North America Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 7: North America Market Value (US$ Mn) Forecast by Therapy Type, 2017-2032 Table 8: North America Market Value (US$ Mn) Forecast by Indication, 2017-2032 Table 9: North America Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 10: North America Market Value (US$ Mn) Forecast by Stem Cell Type, 2017-2032 Table 11: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 12: Latin America Market Value (US$ Mn) Forecast by Therapy Type, 2017-2032 Table 13: Latin America Market Value (US$ Mn) Forecast by Indication, 2017-2032 Table 14: Latin America Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 15: Latin America Market Value (US$ Mn) Forecast by Stem Cell Type, 2017-2032 Table 16: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 17: Europe Market Value (US$ Mn) Forecast by Therapy Type, 2017-2032 Table 18: Europe Market Value (US$ Mn) Forecast by Indication, 2017-2032 Table 19: Europe Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 20: Europe Market Value (US$ Mn) Forecast by Stem Cell Type, 2017-2032 Table 21: East Asia Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 22: East Asia Market Value (US$ Mn) Forecast by Therapy Type, 2017-2032 Table 23: East Asia Market Value (US$ Mn) Forecast by Indication, 2017-2032 Table 24: East Asia Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 25: East Asia Market Value (US$ Mn) Forecast by Stem Cell Type, 2017-2032 Table 26: South Asia & Pacific Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 27: South Asia & Pacific Market Value (US$ Mn) Forecast by Therapy Type, 2017-2032 Table 28: South Asia & Pacific Market Value (US$ Mn) Forecast by Indication, 2017-2032 Table 29: South Asia & Pacific Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 30: South Asia & Pacific Market Value (US$ Mn) Forecast by Stem Cell Type, 2017-2032 Table 31: MEA Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 32: MEA Market Value (US$ Mn) Forecast by Therapy Type, 2017-2032 Table 33: MEA Market Value (US$ Mn) Forecast by Indication, 2017-2032 Table 34: MEA Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 35: MEA Market Value (US$ Mn) Forecast by Stem Cell Type, 2017-2032
List of Charts
Figure 1: Global Market Value (US$ Mn) by Therapy Type, 2022-2032 Figure 2: Global Market Value (US$ Mn) by Indication, 2022-2032 Figure 3: Global Market Value (US$ Mn) by End User, 2022-2032 Figure 4: Global Market Value (US$ Mn) by Stem Cell Type, 2022-2032 Figure 5: Global Market Value (US$ Mn) by Region, 2022-2032 Figure 6: Global Market Value (US$ Mn) Analysis by Region, 2017-2032 Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032 Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032 Figure 9: Global Market Value (US$ Mn) Analysis by Therapy Type, 2017-2032 Figure 10: Global Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032 Figure 11: Global Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032 Figure 12: Global Market Value (US$ Mn) Analysis by Indication, 2017-2032 Figure 13: Global Market Value Share (%) and BPS Analysis by Indication, 2022-2032 Figure 14: Global Market Y-o-Y Growth (%) Projections by Indication, 2022-2032 Figure 15: Global Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 16: Global Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 17: Global Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 18: Global Market Value (US$ Mn) Analysis by Stem Cell Type, 2017-2032 Figure 19: Global Market Value Share (%) and BPS Analysis by Stem Cell Type, 2022-2032 Figure 20: Global Market Y-o-Y Growth (%) Projections by Stem Cell Type, 2022-2032 Figure 21: Global Market Attractiveness by Therapy Type, 2022-2032 Figure 22: Global Market Attractiveness by Indication, 2022-2032 Figure 23: Global Market Attractiveness by End User, 2022-2032 Figure 24: Global Market Attractiveness by Stem Cell Type, 2022-2032 Figure 25: Global Market Attractiveness by Region, 2022-2032 Figure 26: North America Market Value (US$ Mn) by Therapy Type, 2022-2032 Figure 27: North America Market Value (US$ Mn) by Indication, 2022-2032 Figure 28: North America Market Value (US$ Mn) by End User, 2022-2032 Figure 29: North America Market Value (US$ Mn) by Stem Cell Type, 2022-2032 Figure 30: North America Market Value (US$ Mn) by Country, 2022-2032 Figure 31: North America Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 34: North America Market Value (US$ Mn) Analysis by Therapy Type, 2017-2032 Figure 35: North America Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032 Figure 36: North America Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032 Figure 37: North America Market Value (US$ Mn) Analysis by Indication, 2017-2032 Figure 38: North America Market Value Share (%) and BPS Analysis by Indication, 2022-2032 Figure 39: North America Market Y-o-Y Growth (%) Projections by Indication, 2022-2032 Figure 40: North America Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 41: North America Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 42: North America Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 43: North America Market Value (US$ Mn) Analysis by Stem Cell Type, 2017-2032 Figure 44: North America Market Value Share (%) and BPS Analysis by Stem Cell Type, 2022-2032 Figure 45: North America Market Y-o-Y Growth (%) Projections by Stem Cell Type, 2022-2032 Figure 46: North America Market Attractiveness by Therapy Type, 2022-2032 Figure 47: North America Market Attractiveness by Indication, 2022-2032 Figure 48: North America Market Attractiveness by End User, 2022-2032 Figure 49: North America Market Attractiveness by Stem Cell Type, 2022-2032 Figure 50: North America Market Attractiveness by Country, 2022-2032 Figure 51: Latin America Market Value (US$ Mn) by Therapy Type, 2022-2032 Figure 52: Latin America Market Value (US$ Mn) by Indication, 2022-2032 Figure 53: Latin America Market Value (US$ Mn) by End User, 2022-2032 Figure 54: Latin America Market Value (US$ Mn) by Stem Cell Type, 2022-2032 Figure 55: Latin America Market Value (US$ Mn) by Country, 2022-2032 Figure 56: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 59: Latin America Market Value (US$ Mn) Analysis by Therapy Type, 2017-2032 Figure 60: Latin America Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032 Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032 Figure 62: Latin America Market Value (US$ Mn) Analysis by Indication, 2017-2032 Figure 63: Latin America Market Value Share (%) and BPS Analysis by Indication, 2022-2032 Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Indication, 2022-2032 Figure 65: Latin America Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 66: Latin America Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 67: Latin America Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 68: Latin America Market Value (US$ Mn) Analysis by Stem Cell Type, 2017-2032 Figure 69: Latin America Market Value Share (%) and BPS Analysis by Stem Cell Type, 2022-2032 Figure 70: Latin America Market Y-o-Y Growth (%) Projections by Stem Cell Type, 2022-2032 Figure 71: Latin America Market Attractiveness by Therapy Type, 2022-2032 Figure 72: Latin America Market Attractiveness by Indication, 2022-2032 Figure 73: Latin America Market Attractiveness by End User, 2022-2032 Figure 74: Latin America Market Attractiveness by Stem Cell Type, 2022-2032 Figure 75: Latin America Market Attractiveness by Country, 2022-2032 Figure 76: Europe Market Value (US$ Mn) by Therapy Type, 2022-2032 Figure 77: Europe Market Value (US$ Mn) by Indication, 2022-2032 Figure 78: Europe Market Value (US$ Mn) by End User, 2022-2032 Figure 79: Europe Market Value (US$ Mn) by Stem Cell Type, 2022-2032 Figure 80: Europe Market Value (US$ Mn) by Country, 2022-2032 Figure 81: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 84: Europe Market Value (US$ Mn) Analysis by Therapy Type, 2017-2032 Figure 85: Europe Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032 Figure 86: Europe Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032 Figure 87: Europe Market Value (US$ Mn) Analysis by Indication, 2017-2032 Figure 88: Europe Market Value Share (%) and BPS Analysis by Indication, 2022-2032 Figure 89: Europe Market Y-o-Y Growth (%) Projections by Indication, 2022-2032 Figure 90: Europe Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 91: Europe Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 92: Europe Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 93: Europe Market Value (US$ Mn) Analysis by Stem Cell Type, 2017-2032 Figure 94: Europe Market Value Share (%) and BPS Analysis by Stem Cell Type, 2022-2032 Figure 95: Europe Market Y-o-Y Growth (%) Projections by Stem Cell Type, 2022-2032 Figure 96: Europe Market Attractiveness by Therapy Type, 2022-2032 Figure 97: Europe Market Attractiveness by Indication, 2022-2032 Figure 98: Europe Market Attractiveness by End User, 2022-2032 Figure 99: Europe Market Attractiveness by Stem Cell Type, 2022-2032 Figure 100: Europe Market Attractiveness by Country, 2022-2032 Figure 101: East Asia Market Value (US$ Mn) by Therapy Type, 2022-2032 Figure 102: East Asia Market Value (US$ Mn) by Indication, 2022-2032 Figure 103: East Asia Market Value (US$ Mn) by End User, 2022-2032 Figure 104: East Asia Market Value (US$ Mn) by Stem Cell Type, 2022-2032 Figure 105: East Asia Market Value (US$ Mn) by Country, 2022-2032 Figure 106: East Asia Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 107: East Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 108: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 109: East Asia Market Value (US$ Mn) Analysis by Therapy Type, 2017-2032 Figure 110: East Asia Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032 Figure 111: East Asia Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032 Figure 112: East Asia Market Value (US$ Mn) Analysis by Indication, 2017-2032 Figure 113: East Asia Market Value Share (%) and BPS Analysis by Indication, 2022-2032 Figure 114: East Asia Market Y-o-Y Growth (%) Projections by Indication, 2022-2032 Figure 115: East Asia Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 116: East Asia Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 117: East Asia Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 118: East Asia Market Value (US$ Mn) Analysis by Stem Cell Type, 2017-2032 Figure 119: East Asia Market Value Share (%) and BPS Analysis by Stem Cell Type, 2022-2032 Figure 120: East Asia Market Y-o-Y Growth (%) Projections by Stem Cell Type, 2022-2032 Figure 121: East Asia Market Attractiveness by Therapy Type, 2022-2032 Figure 122: East Asia Market Attractiveness by Indication, 2022-2032 Figure 123: East Asia Market Attractiveness by End User, 2022-2032 Figure 124: East Asia Market Attractiveness by Stem Cell Type, 2022-2032 Figure 125: East Asia Market Attractiveness by Country, 2022-2032 Figure 126: South Asia & Pacific Market Value (US$ Mn) by Therapy Type, 2022-2032 Figure 127: South Asia & Pacific Market Value (US$ Mn) by Indication, 2022-2032 Figure 128: South Asia & Pacific Market Value (US$ Mn) by End User, 2022-2032 Figure 129: South Asia & Pacific Market Value (US$ Mn) by Stem Cell Type, 2022-2032 Figure 130: South Asia & Pacific Market Value (US$ Mn) by Country, 2022-2032 Figure 131: South Asia & Pacific Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 132: South Asia & Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 133: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 134: South Asia & Pacific Market Value (US$ Mn) Analysis by Therapy Type, 2017-2032 Figure 135: South Asia & Pacific Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032 Figure 136: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032 Figure 137: South Asia & Pacific Market Value (US$ Mn) Analysis by Indication, 2017-2032 Figure 138: South Asia & Pacific Market Value Share (%) and BPS Analysis by Indication, 2022-2032 Figure 139: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Indication, 2022-2032 Figure 140: South Asia & Pacific Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 141: South Asia & Pacific Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 142: South Asia & Pacific Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 143: South Asia & Pacific Market Value (US$ Mn) Analysis by Stem Cell Type, 2017-2032 Figure 144: South Asia & Pacific Market Value Share (%) and BPS Analysis by Stem Cell Type, 2022-2032 Figure 145: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Stem Cell Type, 2022-2032 Figure 146: South Asia & Pacific Market Attractiveness by Therapy Type, 2022-2032 Figure 147: South Asia & Pacific Market Attractiveness by Indication, 2022-2032 Figure 148: South Asia & Pacific Market Attractiveness by End User, 2022-2032 Figure 149: South Asia & Pacific Market Attractiveness by Stem Cell Type, 2022-2032 Figure 150: South Asia & Pacific Market Attractiveness by Country, 2022-2032 Figure 151: MEA Market Value (US$ Mn) by Therapy Type, 2022-2032 Figure 152: MEA Market Value (US$ Mn) by Indication, 2022-2032 Figure 153: MEA Market Value (US$ Mn) by End User, 2022-2032 Figure 154: MEA Market Value (US$ Mn) by Stem Cell Type, 2022-2032 Figure 155: MEA Market Value (US$ Mn) by Country, 2022-2032 Figure 156: MEA Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 157: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 158: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 159: MEA Market Value (US$ Mn) Analysis by Therapy Type, 2017-2032 Figure 160: MEA Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032 Figure 161: MEA Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032 Figure 162: MEA Market Value (US$ Mn) Analysis by Indication, 2017-2032 Figure 163: MEA Market Value Share (%) and BPS Analysis by Indication, 2022-2032 Figure 164: MEA Market Y-o-Y Growth (%) Projections by Indication, 2022-2032 Figure 165: MEA Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 166: MEA Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 167: MEA Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 168: MEA Market Value (US$ Mn) Analysis by Stem Cell Type, 2017-2032 Figure 169: MEA Market Value Share (%) and BPS Analysis by Stem Cell Type, 2022-2032 Figure 170: MEA Market Y-o-Y Growth (%) Projections by Stem Cell Type, 2022-2032 Figure 171: MEA Market Attractiveness by Therapy Type, 2022-2032 Figure 172: MEA Market Attractiveness by Indication, 2022-2032 Figure 173: MEA Market Attractiveness by End User, 2022-2032 Figure 174: MEA Market Attractiveness by Stem Cell Type, 2022-2032 Figure 175: MEA Market Attractiveness by Country, 2022-2032
Recommendations
Explore Healthcare Insights
View Reports